Hypertension is a major risk factor in the development of heart failure (HF), yet current guidelines do not specify a target blood pressure (BP) for patients with established systolic or diastolic left ventricular (LV) dysfunction. While no randomized controlled trial (RCT) has been conducted to specify the optimal blood pressure in these patients, numerous trials have demonstrated the benefits of certain classes of medications and treatment strategies in patients with HF. Important factors to consider in treating hypertension in patients with HF include the type of HF (reduced vs. preserved ejection fraction), the etiology (ischemic vs. nonischemic), the severity of symptoms if any, the baseline blood pressure, as well as a wide variety of...
None of the available outcome-based studies was primarily designed to compare different blood pressu...
BackgroundNew hypertension and heart failure guidelines recommend that systolic blood pressure (SBP)...
Left ventricular hypertrophy is a common feature of essential hypertension, and represents at the sa...
Hypertension is a common comorbidity in patients with heart failure and most drugs that have demonst...
Background Hypertension is a leading cause of cardiovascular disease, stroke, and d...
Background: Prescribed dosages of heart failure (HF) therapy in patients with a reduced left ventric...
BACKGROUND: National guidelines recommend that systolic blood pressure (SBP) in patients with heart ...
Abstract Hypertension is highly prevalent worldwide and is the major risk factor for heart failure (...
Background: The development and risk potential of hypertension-induced left ventricular (LV) hypertr...
Although patients hospitalized with heart failure have relatively low in-hospital mortality, the pos...
Left ventricular hypertrophy is a maladaptive response to chronic pressure overload and an important...
International audienceLow blood pressure is common in patients with heart failure and reduced ejecti...
AbstractArterial hypertension, alone or in combination with ischemic heart disease, precedes the dev...
© American Journal of Hypertension, Ltd 2020. All rights reserved. For Permissions, please email: jo...
None of the available outcome-based studies was primarily designed to compare different blood pressu...
BackgroundNew hypertension and heart failure guidelines recommend that systolic blood pressure (SBP)...
Left ventricular hypertrophy is a common feature of essential hypertension, and represents at the sa...
Hypertension is a common comorbidity in patients with heart failure and most drugs that have demonst...
Background Hypertension is a leading cause of cardiovascular disease, stroke, and d...
Background: Prescribed dosages of heart failure (HF) therapy in patients with a reduced left ventric...
BACKGROUND: National guidelines recommend that systolic blood pressure (SBP) in patients with heart ...
Abstract Hypertension is highly prevalent worldwide and is the major risk factor for heart failure (...
Background: The development and risk potential of hypertension-induced left ventricular (LV) hypertr...
Although patients hospitalized with heart failure have relatively low in-hospital mortality, the pos...
Left ventricular hypertrophy is a maladaptive response to chronic pressure overload and an important...
International audienceLow blood pressure is common in patients with heart failure and reduced ejecti...
AbstractArterial hypertension, alone or in combination with ischemic heart disease, precedes the dev...
© American Journal of Hypertension, Ltd 2020. All rights reserved. For Permissions, please email: jo...
None of the available outcome-based studies was primarily designed to compare different blood pressu...
BackgroundNew hypertension and heart failure guidelines recommend that systolic blood pressure (SBP)...
Left ventricular hypertrophy is a common feature of essential hypertension, and represents at the sa...